Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03243734 · ClinicalTrials.gov registry record · NA
trūFreeze® Palliative Esophageal Cancer
A NA study, sponsored by US Endoscopy Group.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03243734 is a NA study that has completed, run by US Endoscopy Group. The registered enrollment target is 49 participants.
The verdict
NCT03243734, a NA study, has completed, sponsored by US Endoscopy Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Prospective, open label, non-controlled single arm, multi-center study The primary objective is to study the effects of the trūFreeze® Spray Cryotherapy System in a population of subjects who have been diagnosed with persistent local esophageal cancer and who are not surgical candidates or have completed or declined systemic therapy.
Interventions
- DEVICE trūFreeze® System spray cryotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2024-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03243734
The ClinicalTrials.gov registry entry for NCT03243734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Endoscopy Group, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which trūFreeze® System spray cryotherapy is the first listed.
NCT03243734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03243734 about?
NCT03243734 is a clinical study titled "trūFreeze® Palliative Esophageal Cancer". Prospective, open label, non-controlled single arm, multi-center study The primary objective is to study the effects of the trūFreeze® Spray Cryotherapy System in a population of subjects who have been diagnosed with persistent local esophageal cancer and who are not surgical candidates or have comp...
What is the current status of trial NCT03243734?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2017-11-06. Estimated completion is 2024-03-06.
What interventions are being tested in trial NCT03243734?
The interventions under investigation include: trūFreeze® System spray cryotherapy (DEVICE).
Who is sponsoring clinical trial NCT03243734?
This trial is sponsored by US Endoscopy Group, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.